Mode of action based risk assessment of the botanical food-borne alkenylbenzene apiol from parsley using physiologically based kinetic (PBK) modelling and read-across from safrole.
暂无分享,去创建一个
Ivonne M C M Rietjens | Jacques Vervoort | J. Vervoort | I. Rietjens | S. Wesseling | Ans E M F Soffers | A. Soffers | Ala A A Al-Subeihi | Sebastiaan Wesseling | Abdalmajeed M Alajlouni | Amer J Al Malahmeh | Reiko Kiwamoto | A. Al-Subeihi | R. Kiwamoto
[1] E C Miller,et al. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. , 1983, Cancer research.
[2] J. A. Bond,et al. In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. , 1994, Carcinogenesis.
[3] P. van Bladeren,et al. Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat. , 2012, Toxicology and applied pharmacology.
[4] J. Miller,et al. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens. , 1976, Cancer research.
[5] J. Vervoort,et al. Physiologically based kinetic models for the alkenylbenzene elemicin in rat and human and possible implications for risk assessment. , 2012, Chemical research in toxicology.
[6] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[7] J. Caldwell,et al. Dose dependent conversion of estragole in the rat and mouse to the carcinogenic metabolite, 1'-hydroxyestragole. , 1981, Biochemical pharmacology.
[8] A. Broillet,et al. Absorption, metabolism and excretion of safrole in the rat and man. , 1977, Toxicology.
[9] J. DeJongh,et al. A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans , 1997, Archives of Toxicology.
[10] Ans Punt,et al. Physiologically based biokinetic (PBBK) modeling of safrole bioactivation and detoxification in humans as compared with rats. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[11] H. Maurer,et al. Abuse of Nutmeg (Myristica fragrans Houtt.): Studies on the Metabolism and the Toxicologic Detection of its Ingredients Elemicin, Myristicin, and Safrole in Rat and Human Urine Using Gas Chromatography/Mass Spectrometry , 2006, Therapeutic drug monitoring.
[12] T. J. Zachariah,et al. Chemistry of Spices , 2008 .
[13] K Randerath,et al. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice. , 1984, Carcinogenesis.
[14] Benoît Schilter,et al. A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat. , 2008, Toxicology and applied pharmacology.
[15] T. Guenthner,et al. Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases. , 1992, Drug metabolism and disposition: the biological fate of chemicals.
[16] Andreas P. Freidig,et al. Use of Physiologically Based Biokinetic (PBBK) Modeling to Study Estragole Bioactivation and Detoxification in Humans as Compared with Male Rats , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[17] T. Jeong,et al. In vitro and in vivo metabolism of myristicin in the rat. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[18] E. Sudhölter,et al. Human cytochrome p450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1'-hydroxysafrole. , 2004, Chemical research in toxicology.
[19] E C Miller,et al. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J x C3H/HeJ F1 mice. , 1987, Cancer research.
[20] Ans Punt,et al. Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[21] P. Restani,et al. Levels of Genotoxic and Carcinogenic Compounds in Plant Food Supplements and Associated Risk Assessment , 2011 .
[22] T. Guenthner,et al. Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogs. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[23] Jia Bi,et al. DNA adducts from alkoxyallylbenzene herb and spice constituents in cultured human (HepG2) cells , 2007, Environmental and molecular mutagenesis.
[24] T. Guenthner,et al. Investigation of the role of the 2',3'-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs. , 2001, Toxicology.
[25] A. Punt,et al. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats. , 2011, Chemical research in toxicology.
[26] A. Yarat,et al. Effect of parsley (Petroselinum crispum) on the skin of STZ induced diabetic rats , 1999, Phytotherapy research : PTR.